Targeted Cell Therapies (United States)
- Research works
- 1 fractional, all time
- Citations
- 1 2.0 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 100% world 28%
Not ranked overall: Targeted Cell Therapies (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Targeted Cell Therapies (United States) publish most on?
By volume in 2022–2025: Advanced Breast Cancer Therapies, Ubiquitin and proteasome pathways, interferon and immune responses and Cytokine Signaling Pathways and Interactions.
- 1 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works
- 2 Ubiquitin and proteasome pathways Molecular Biology 0 works
- 3 interferon and immune responses Immunology 0 works
- 4 Cytokine Signaling Pathways and Interactions Oncology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
Other research institutions in Worcester
- University of Massachusetts Chan Medical School
- Worcester Polytechnic Institute
- Clark University
- College of the Holy Cross
- UMass Memorial Health Care
- Worcester State University
- UMass Memorial Medical Center
- Eunice Kennedy Shriver Center
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.